Real World Alliance Drives RWE Innovation with Recent Additions

In April, the Real World Alliance added five members, ConcertAI, Verana Health, OM1, Verily, and Syneos Health. This addition doubled the numbers of the alliance, which was brought together to support the use of real-world evidence (RWE) in regulatory decision-making. The founding members of the Alliance look forward to working with the new members, and have made concerted efforts in the months following their joining.

According to the Alliance, “Since the Alliance launched in May 2021, regulators and policymakers have continued to recognize the need for new policies to help advance innovations to realize the full potential of data to benefit patients. As FDA refines new RWD/E draft guidance documents, the Administration relaunches the Cancer Moonshot, and congressional policymakers consider bipartisan health legislation such as the FDA user fee reauthorization, PREVENT Pandemics Act, and Cures 2.0, among other policy developments, the value of a unified, expert voice on RWE policy becomes increasingly clear.”

To read more, click here.

(Source: RWE Alliance, April 5th, 2022)